Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Vanda Pharmaceuticals Inc. | StockGist | StockGist

Companies
VNDA
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings VNDASCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Vanda Pharmaceuticals Inc.

Filed Jul 1, 2025

Accepted Jun 30, 2025, 8:00 PM ET

CIK 0001347178

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Vanda Pharmaceuticals Inc.

Person Type

OO

CUSIP: 921659108

Amendment History

6 filings

SCHEDULE 13G
Original
Viewing
Jul 1, 20250001104659-25-064754
SCHEDULE 13G/A
Amendment 1
Feb 5, 20250002012383-25-001341
SCHEDULE 13G/A
Amendment 2
Feb 7, 20250002052113-25-000166
SCHEDULE 13G/A
Amendment 3
Jan 9, 20260001104659-26-002483
SCHEDULE 13G/A
Amendment 4
Jan 21, 20260002052113-26-000212
SCHEDULE 13G/A
Amendment 5
Latest
Mar 27, 20260000102909-26-002588

Recent Filings

Vanda Pharmaceuticals Inc.3 days ago

Vanda Pharmaceuticals Inc.1 weeks ago

Vanda Pharmaceuticals Inc.3 weeks ago

Vanda Pharmaceuticals Inc.1 months ago

Vanda Pharmaceuticals Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice